Form 10-Q
Table of Contents

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

 

x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from             to             

Commission File Number 1-898

 

 

AMPCO-PITTSBURGH CORPORATION

 

 

 

Pennsylvania   25-1117717
(State of Incorporation)   (I.R.S. Employer Identification No.)

600 Grant Street, Suite 4600

Pittsburgh, Pennsylvania 15219

(Address of principal executive offices)

(412)456-4400

(Registrant’s telephone number)

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes  x    No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “accelerated filer”, “large accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨    Smaller reporting company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ¨    No  x

On May 4, 2012, 10,342,756 common shares were outstanding.

 

 

 


Table of Contents

AMPCO-PITTSBURGH CORPORATION

INDEX

 

    

Page

No.

 

Part I – Financial Information:

  
 

Item 1 –

    

Financial Statements (Unaudited)

  
      

Condensed Consolidated Balance Sheets – March 31, 2012 and December 31, 2011

     3   
      

Condensed Consolidated Statements of Operations – Three Months Ended March 31, 2012 and 2011

     4   
      

Condensed Consolidated Statements of Comprehensive Income – Three Months Ended March  31, 2012 and 2011

     5   
      

Condensed Consolidated Statements of Cash Flows – Three Months Ended March 31, 2012 and 2011

     6   
      

Notes to Condensed Consolidated Financial Statements

     7   
 

Item 2 –

    

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     17   
 

Item 3 –

    

Quantitative and Qualitative Disclosures About Market Risk

     19   
 

Item 4 –

    

Controls and Procedures

     19   

Part II – Other Information:

  
 

Item 1 –

    

Legal Proceedings

     20   
 

Item 1A –

    

Risk Factors

     20   
 

Item 6 –

    

Exhibits

     20   
 

Signatures

          21   
 

Exhibit Index

     22   
 

Exhibits

       
      

Exhibit 31.1

  
      

Exhibit 31.2

  
      

Exhibit 32.1

  
      

Exhibit 32.2

  
      

Exhibit 101

  

 

2


Table of Contents

PART I – FINANCIAL INFORMATION

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

 

     March 31,
2012
    December 31,
2011
 

Assets

    

Current assets:

    

Cash and cash equivalents

   $ 77,722,736      $ 69,887,839   

Receivables, less allowance for doubtful accounts of $138,687 in 2012 and $140,582 in 2011

     46,545,205        59,210,733   

Inventories

     75,062,770        68,544,000   

Insurance receivables – asbestos

     18,000,000        18,000,000   

Other current assets

     13,366,182        12,888,528   
  

 

 

   

 

 

 

Total current assets

     230,696,893        228,531,100   

Property, plant and equipment, net

     150,913,500        150,239,845   

Insurance receivables – asbestos

     105,056,234        108,419,004   

Investments in joint ventures

     14,551,220        14,872,595   

Deferred tax assets

     23,549,151        23,637,546   

Other noncurrent assets

     6,196,798        5,932,335   
  

 

 

   

 

 

 
   $ 530,963,796      $ 531,632,425   
  

 

 

   

 

 

 

Liabilities and Shareholders’ Equity

    

Current liabilities:

    

Accounts payable

   $ 16,538,615      $ 19,528,382   

Accrued payrolls and employee benefits

     10,184,094        10,982,902   

Industrial Revenue Bond debt

     13,311,000        13,311,000   

Asbestos liability – current portion

     25,000,000        25,000,000   

Other current liabilities

     23,217,411        20,337,409   
  

 

 

   

 

 

 

Total current liabilities

     88,251,120        89,159,693   

Employee benefit obligations

     76,158,681        75,257,001   

Asbestos liability

     168,075,762        172,872,255   

Other noncurrent liabilities

     1,580,683        1,471,863   
  

 

 

   

 

 

 

Total liabilities

     334,066,246        338,760,812   
  

 

 

   

 

 

 

Commitments and contingent liabilities (Note 6)

    

Shareholders’ equity:

    

Common stock – par value $1; authorized 20,000,000 shares; issued and outstanding 10,331,436 shares in 2012 and 10,325,602 shares in 2011

     10,331,436        10,325,602   

Additional paid-in capital

     123,522,673        123,088,241   

Retained earnings

     138,888,110        138,747,964   

Accumulated other comprehensive loss

     (75,844,669     (79,290,194
  

 

 

   

 

 

 

Total shareholders’ equity

     196,897,550        192,871,613   
  

 

 

   

 

 

 
   $ 530,963,796      $ 531,632,425   
  

 

 

   

 

 

 

See Notes to Condensed Consolidated Financial Statements.

 

3


Table of Contents

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED)

 

     Three Months Ended March 31,  
     2012     2011  

Net sales

   $ 73,605,120      $ 89,068,041   
  

 

 

   

 

 

 

Operating costs and expenses:

    

Costs of products sold (excluding depreciation)

     56,236,453        63,394,143   

Selling and administrative

     10,427,398        10,881,611   

Depreciation

     2,824,611        2,663,768   
  

 

 

   

 

 

 

Total operating expenses

     69,488,462        76,939,522   
  

 

 

   

 

 

 

Income from operations

     4,116,658        12,128,519   
  

 

 

   

 

 

 

Other income (expense):

    

Investment-related income

     16,390        22,544   

Interest expense

     (56,012     (76,769

Other – net

     (236,722     (454,649
  

 

 

   

 

 

 
     (276,344     (508,874
  

 

 

   

 

 

 

Income before income taxes and equity losses in Chinese joint venture

     3,840,314        11,619,645   

Income tax provision

     (1,375,000     (3,873,000

Equity losses in Chinese joint venture

     (465,763     (70,068
  

 

 

   

 

 

 

Net income

   $ 1,999,551      $ 7,676,577   
  

 

 

   

 

 

 

Net income per common share:

    

Basic

   $ 0.19      $ 0.74   
  

 

 

   

 

 

 

Diluted

   $ 0.19      $ 0.74   
  

 

 

   

 

 

 

Cash dividends declared per share

   $ 0.18      $ 0.18   
  

 

 

   

 

 

 

Weighted average number of common shares outstanding:

    

Basic

     10,329,000        10,305,156   
  

 

 

   

 

 

 

Diluted

     10,393,165        10,366,991   
  

 

 

   

 

 

 

See Notes to Condensed Consolidated Financial Statements.

 

4


Table of Contents

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(UNAUDITED)

 

     Three Months Ended March 31,  
     2012     2011  

Net income

   $ 1,999,551      $ 7,676,577   
  

 

 

   

 

 

 

Other comprehensive income (loss), net of tax where applicable:

    

Adjustments for changes in:

    

Foreign exchange translation

     1,742,260        1,432,831   

Unrealized holding gains on marketable securities

     109,850        103,087   

Fair value of cash flow hedges

     225,511        (130,769

Reclassification adjustments for items included in net income:

    

Amortization of unrecognized employee benefit costs

     1,266,196        831,495   

Realized gains on sale of marketable securities

     (20,897     (6,513

Realized losses (gains) from settlement of cash flow hedges

     122,605        (430,019
  

 

 

   

 

 

 

Other comprehensive income

     3,445,525        1,800,112   
  

 

 

   

 

 

 

Comprehensive income

   $ 5,445,076      $ 9,476,689   
  

 

 

   

 

 

 

See Notes to Condensed Consolidated Financial Statements.

 

5


Table of Contents

AMPCO-PITTSBURGH CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

     Three Months Ended March 31,  
     2012     2011  

Net cash flows provided by operating activities

   $ 11,858,738      $ 4,349,701   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property, plant and equipment

     (2,732,673     (2,301,908

Purchases of long-term marketable securities

     (179,166     (191,942

Proceeds from sale of long-term marketable securities

     153,257        181,404   

Proceeds from U.K. government grant

     0        484,499   
  

 

 

   

 

 

 

Net cash flows used in investing activities

     (2,758,582     (1,827,947
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Dividends paid

     (1,858,608     (1,854,928

Proceeds from the issuance of common stock

     78,000        0   

Excess tax benefits from the exercise of stock options

     13,130        0   
  

 

 

   

 

 

 

Net cash flows used in financing activities

     (1,767,478     (1,854,928
  

 

 

   

 

 

 

Effect of exchange rate changes on cash and cash equivalents

     502,219        283,992   
  

 

 

   

 

 

 

Net increase in cash and cash equivalents

     7,834,897        950,818   

Cash and cash equivalents at beginning of period

     69,887,839        70,020,838   
  

 

 

   

 

 

 

Cash and cash equivalents at end of period

   $ 77,722,736      $ 70,971,656   
  

 

 

   

 

 

 

Supplemental information:

    

Income tax payments

   $ 996,964      $ 213,288   
  

 

 

   

 

 

 

Interest payments

   $ 56,010      $ 77,041   
  

 

 

   

 

 

 

Non-cash investing activities:

    

Purchases of property, plant and equipment included in accounts payable

   $ 691,902      $ 1,356,068   
  

 

 

   

 

 

 

See Notes to Condensed Consolidated Financial Statements.

 

6


Table of Contents

AMPCO-PITTSBURGH CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

 

1. Unaudited Condensed Consolidated Financial Statements

The condensed consolidated balance sheet as of March 31, 2012 and the condensed consolidated statements of operations, comprehensive income and cash flows for the three months ended March 31, 2012 and 2011 have been prepared by Ampco-Pittsburgh Corporation (the Corporation) without audit. In the opinion of management, all adjustments, consisting of only normal and recurring adjustments necessary to present fairly the financial position, results of operations and cash flows for the periods presented, have been made. The results of operations for the three months ended March 31, 2012 are not necessarily indicative of the operating results expected for the full year.

Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted.

Recently Implemented Accounting Pronouncements

In May 2011, the Financial Accounting Standards Board (FASB) issued ASU 2011-04, Fair Value Measurement: Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRSs. ASU 2011-04 is to be applied prospectively and is effective for the Corporation for interim and annual periods beginning in 2012. The guidance primarily changes the wording used to describe many of the requirements in U.S. GAAP for measuring fair value and for disclosing information about fair value measurements and did not impact operating results, financial position or liquidity of the Corporation.

In June 2011, the FASB issued ASU 2011-05, Comprehensive Income, which eliminates the option to present other comprehensive income and its components as part of the statement of shareholders’ equity. All non-owner changes in shareholders’ equity will be presented either in a single continuous statement along with net income or in a separate statement immediately following the statement of income. ASU 2011-05 is to be applied retrospectively and is effective for the Corporation for interim and annual periods beginning in 2012. The guidance does not change whether items are reported in net income or other comprehensive income or when items in other comprehensive income are reclassified to net income; accordingly, adoption of ASU 2011-05 did not impact operating results, financial position or liquidity of the Corporation. The Corporation elected to present other comprehensive income and its components as a separate statement immediately following its condensed consolidated statements of operations.

Recently Issued Accounting Pronouncements

In December 2011, the FASB issued ASU 2011-11, Disclosures about Offsetting Assets and Liabilities, which requires expanded disclosures, including gross and net information, about financial and derivative instruments that are either offset in the balance sheet or are subject to an enforceable master netting arrangement or similar agreement. The guidance is effective for reporting periods beginning on or after January 1, 2013 and is to be applied retrospectively. The new guidance affects disclosures only and will not impact operating results, financial position or liquidity of the Corporation.

 

7


Table of Contents
2. Inventories

At March 31, 2012 and December 31, 2011, approximately 62% of the inventories were valued on the LIFO method with the remaining inventories valued on the FIFO method. Inventories were comprised of the following:

 

     (in thousands)  
     March 31,
2012
     December 31,
2011
 

Raw materials

   $ 19,602       $ 20,798   

Work-in-process

     32,427         29,314   

Finished goods

     11,763         7,835   

Supplies

     11,271         10,597   
  

 

 

    

 

 

 
   $     75,063       $ 68,544   
  

 

 

    

 

 

 

 

3. Property, Plant and Equipment

Property, plant and equipment were comprised of the following:

 

     (in thousands)  
     March 31,
2012
    December 31,
2011
 

Land and land improvements

   $ 4,974      $ 4,974   

Buildings

     41,473        41,433   

Machinery and equipment

     225,085        224,426   

Construction-in-progress

     15,348        12,446   

Other

     8,451        8,419   
  

 

 

   

 

 

 
     295,331        291,698   

Accumulated depreciation

     (144,417     (141,458
  

 

 

   

 

 

 
   $ 150,914      $ 150,240   
  

 

 

   

 

 

 

Land and buildings of Union Electric Steel UK Limited (UES-UK) equal to approximately $1,300,000 (£836,000) at March 31, 2012 are held as collateral by the trustees of the UES-UK contributory defined benefit pension plan (see Note 5).

 

4. Other Current Liabilities

Other current liabilities were comprised of the following:

 

     (in thousands)  
     March 31,
2012
     December 31,
2011
 

Customer-related liabilities

   $ 11,126       $ 10,506   

Accrued sales commissions

     1,841         2,245   

Dividend payable

     1,859         1,859   

Other

     8,391         5,727   
  

 

 

    

 

 

 
   $     23,217       $ 20,337   
  

 

 

    

 

 

 

 

8


Table of Contents

Included in customer-related liabilities are costs expected to be incurred with respect to product warranties. Changes in the liability for product warranty claims consisted of the following:

 

     (in thousands)  
     Three Months Ended March 31,  
     2012     2011  

Balance at beginning of the period

   $ 5,498      $ 5,113   

Satisfaction of warranty claims

     (692     (640

Provision for warranty claims

     589        599   

Other, primarily impact from changes in foreign currency exchange rates

     77        69   
  

 

 

   

 

 

 

Balance at end of the period

   $ 5,472      $ 5,141   
  

 

 

   

 

 

 

 

5. Pension and Other Postretirement Benefits

Contributions for the three months ended March 31, 2012 and 2011 were as follows:

 

     (in thousands)  
     2012      2011  

U.S. pension benefits plans

   $ 0       $ 0   

U.K. pension benefits plan

   $     444       $     366   

Other postretirement benefits (e.g. net payments)

   $ 137       $ 187   

U.K. defined contribution plan

   $ 78       $ 94   

Net periodic pension and other postretirement costs include the following components:

 

     (in thousands)  
     Three Months Ended March 31,  

U.S. Pension Benefits

   2012     2011  

Service cost

   $ 821      $ 826   

Interest cost

     2,194        2,298   

Expected return on plan assets

     (2,383     (2,291

Amortization of prior service cost

     167        164   

Amortization of actuarial loss

     1,531        958   
  

 

 

   

 

 

 

Net benefit costs

   $ 2,330      $ 1,955   
  

 

 

   

 

 

 
     (in thousands)  
     Three Months Ended March 31,  

U.K. Pension Benefits

   2012     2011  

Interest cost

   $ 623      $ 644   

Expected return on plan assets

     (522     (575

Amortization of actuarial loss

     148        123   
  

 

 

   

 

 

 

Net benefit costs

   $ 249      $ 192   
  

 

 

   

 

 

 
     (in thousands)  
     Three Months Ended March 31,  

Other Postretirement Benefits

   2012     2011  

Service cost

   $ 161      $ 157   

Interest cost

     230        231   

Amortization of prior service cost

     22        21   

Amortization of actuarial loss

     103        28   
  

 

 

   

 

 

 

Net benefit costs

   $ 516      $ 437   
  

 

 

   

 

 

 

 

9


Table of Contents
6. Commitments and Contingent Liabilities

Outstanding standby and commercial letters of credit as of March 31, 2012 approximated $21,204,000, the majority of which serve as collateral for the Industrial Revenue Bond debt.

In 2010, UES-UK was awarded a government grant of up to $1,325,000 (£850,000) toward the purchase and installation of certain machinery and equipment of which $710,000 (£445,000) has been received to date. Under the agreement, the grant is repayable if certain conditions are not met including achieving and maintaining a targeted level of employment through 2017. UES-UK’s level of employment currently exceeds and is expected to continue to exceed the targeted level of employment; accordingly, no liability has been recorded.

See Note 11 regarding litigation and Note 12 for environmental matters.

 

7. Foreign Currency Exchange and Futures Contracts

Certain of the Corporation’s operations are subject to risk from exchange rate fluctuations in connection with sales in foreign currencies. To minimize this risk, foreign currency sales contracts are entered into which are designated as cash flow or fair value hedges and are recorded in the condensed consolidated balance sheet as either an asset or a liability measured at their fair value. The accounting for changes in the fair value of a derivative depends on the use of the derivative. To the extent that a derivative is designated and effective as a cash flow hedge of an exposure to future changes in value, the change in fair value of the derivative is deferred in accumulated other comprehensive income (loss). Any portion considered to be ineffective, including that arising from the unlikelihood of an anticipated transaction to occur, is reported as a component of earnings (other income/expense) immediately. Upon occurrence of the anticipated transaction, the derivative designated and effective as a cash flow hedge is de-designated as a fair value hedge and the change in fair value previously deferred in accumulated other comprehensive income (loss) is reclassified to earnings (net sales) with subsequent changes in fair value recorded as a component of earnings (other income/expense). To the extent that a derivative is designated and effective as a hedge of an exposure to changes in fair value, the change in the derivative’s fair value will be offset in the condensed consolidated statement of operations by the change in the fair value of the item being hedged and is recorded as a component of earnings (other income/expense).

No portion of the existing cash flow or fair value hedges is considered to be ineffective, including any ineffectiveness arising from the unlikelihood of an anticipated transaction to occur. Additionally, no amounts have been excluded from assessing the effectiveness of the hedge.

As of March 31, 2012, approximately $17,909,000 of anticipated foreign-denominated sales has been hedged of which $1,438,000 is covered by cash flow contracts settling at various dates through March 2013 and the remaining $16,471,000 is covered by fair value contracts settling at various dates through September 2013. As of March 31, 2012, the fair value of foreign currency sales contracts designated as cash flow hedges expecting to settle within the next 12 months approximated $132,000 and is recorded as other current assets. The change in the fair value of the contracts is recorded as a component of accumulated other comprehensive income (loss) and approximated $38,000 and $114,000, net of income taxes, as of March 31, 2012 and December 31, 2011, respectively. During the three months ended March 31, 2012, approximately $(26,000), net of income taxes, was recognized as comprehensive income (loss) and $50,000, net of income taxes, was released from accumulated other comprehensive income (loss). The change in the fair value will be reclassified to earnings when the projected sale occurs with approximately $60,000 expected to be released to pretax earnings in the next 12 months. During the three months ended March 31, 2012 and 2011, approximately $79,000 and $183,000, respectively, was released to pre-tax earnings.

As of March 31, 2012, the fair value of foreign currency sales contracts designated as fair value hedges expecting to settle within the next 12 months approximated $521,000 and is recorded as other current assets. (The fair value of the related hedged items, recorded as other current liabilities or a reduction to accounts receivable, approximated $537,000.) The fair value of the remaining fair value hedges equaled $165,000 and is recorded as other noncurrent assets. (The fair value of the related hedged items, recorded as other noncurrent liabilities, approximated $166,000.) The fair value of assets held as collateral as of March 31, 2012 approximated $801,000.

Gains (losses) on foreign exchange transactions included in other income (expense) approximated $27,000 and $(191,000) for the three months ended March 31, 2012 and 2011.

 

10


Table of Contents

In May 2009, the Corporation entered into foreign currency purchase contracts to manage the volatility associated with Euro-denominated progress payments to be made for certain machinery and equipment. All contracts were settled as of December 31, 2010; accordingly, no amounts were recognized as comprehensive income (loss) in 2011 or 2012. Approximately $4,000, net of income taxes, was released from accumulated other comprehensive income (loss) for the three months ended March 31, 2012. The change in the fair value of the contracts is recorded as a component of accumulated other comprehensive income (loss) and approximated $305,000 and $309,000, net of income taxes, as of March 31, 2012 and December 31, 2011, respectively. The change in the fair value is being amortized to pre-tax earnings (as an offset to depreciation expense) over the life of the underlying assets. For the three months ended March 31, 2012 and 2011, approximately $7,000 and $8,000, respectively, was released to pre-tax earnings. Approximately $28,000 is expected to be released to pre-tax earnings within the next 12 months.

At March 31, 2012, the Corporation has purchase commitments covering 60% or $10,048,000 of anticipated natural gas usage over approximately the next four years at one of its subsidiaries. The commitments qualify as normal purchases and, accordingly, are not reflected on the condensed consolidated balance sheet.

One of the Corporation’s subsidiaries is subject to risk from increases in the price of commodities (copper and aluminum) used in the production of inventory. To minimize this risk, futures contracts are entered into which are designated as cash flow hedges. The change in fair value of the derivative is deferred in accumulated other comprehensive income (loss). Any portion considered to be ineffective, including that arising from the unlikelihood of an anticipated transaction to occur, is reported as a component of earnings (other income/expense) immediately. Upon occurrence of the anticipated transaction, the futures contract is settled and the change in fair value previously deferred in accumulated other comprehensive income (loss) is reclassified to earnings (costs of products sold) when the projected sales occur. At March 31, 2012, approximately 57% or $3,294,000 of anticipated copper purchases over the next nine months and 63% or $819,000 of anticipated aluminum purchases over the next six months are hedged. The fair value of these contracts (both outstanding and settled) approximated $184,000 as of March 31, 2012. The change in the fair value of the contracts designated as cash flow hedges is recorded as a component of accumulated other comprehensive income (loss) and approximated $115,000 and $(314,000), net of income taxes, as of March 31, 2012 and December 31, 2011, respectively. During the three months ended March 31, 2012, approximately $252,000, net of income taxes, was recognized as comprehensive income (loss) and $(177,000), net of income taxes, was released from accumulated other comprehensive income (loss). The change in the fair value will be reclassified to earnings when the projected sale occurs with approximately $184,000 expected to be released to pretax earnings in the next 12 months. During the three months ended March 31, 2012 and 2011, approximately $(284,000) and $504,000, respectively, was released to pre-tax earnings. The fair value of assets held as collateral as of March 31, 2012 equaled $500,000.

The Corporation does not enter into derivative transactions for speculative purposes and, therefore, holds no derivative instruments for trading purposes.

 

8. Stock-Based Compensation

In May 2011, the shareholders of the Corporation approved the adoption of the 2011 Omnibus Incentive Plan (Incentive Plan) which authorizes the issuance of up to 1,000,000 shares of the Corporation’s common stock for grants of equity-based compensation. Awards under the Incentive Plan may include incentive non-qualified stock options, stock appreciation rights, restricted shares and restricted stock units, performance awards, other stock-based awards or short-term cash incentive awards. The Incentive Plan is administered by the Compensation Committee of the Board of Directors who has the authority to determine, within the limits of the express provisions of the Incentive Plan, the individuals to whom the awards will be granted; the nature, amount and terms of such awards; and the objectives and conditions for earning such awards. In May 2012, the Compensation Committee granted 164,500 non-qualified stock options to select employees. The options have a ten-year life and vest over a three year period.

Stock-based compensation expense for the three months ended March 31, 2012 and 2011 equaled $349,000 and $348,000, respectively. The related income tax benefit recognized in the condensed consolidated statement of operations for each of the periods was approximately $122,000.

 

11


Table of Contents

The Incentive Plan also provides for annual grants of shares of the Corporation’s common stock to non-employee directors following the Corporation’s annual shareholder meeting. Each annual director award will be for a number of shares having a fair market value equal to $25,000 and will be fully vested as of the grant date. In May 2012, 11,320 shares of the Corporation’s common stock were issued to the non-employee directors.

 

9. Fair Value

The Corporation’s financial assets and liabilities that are reported at fair value in the accompanying condensed consolidated balance sheet as of March 31, 2012 and December 31, 2011 were as follows:

 

     (in thousands)  
     Quoted Prices in
Active  Markets
for Identical
Inputs
(Level 1)
     Significant Other
Observable
Inputs
(Level 2)
    Significant
Unobservable
Inputs
(Level 3)
     Total  

As of March 31, 2012

          

Investments

          

Other noncurrent assets

   $ 3,262       $ 0      $ 0       $       3,262   

Foreign currency exchange contracts

          

Accounts receivable

     0         (98     0         (98

Other current assets

     0         653        0         653   

Other noncurrent assets

     0         165        0         165   

Other current liabilities

     0         439        0         439   

Other noncurrent liabilities

     0         166        0         166   

As of December 31, 2011

          

Investments

          

Other noncurrent assets

   $ 3,090       $ 0      $ 0       $ 3,090   

Foreign currency exchange contracts

          

Other current assets

     0         363        0         363   

Other noncurrent assets

     0         169        0         169   

Other current liabilities

     0         174        0         174   

Other noncurrent liabilities

     0         116        0         116   

 

10. Business Segments

Presented below are the net sales and income before income taxes for the Corporation’s two business segments.

 

     (in thousands)  
     Three Months Ended March 31,  
     2012     2011  

Net sales:

    

Forged and Cast Rolls

   $ 43,948      $ 62,883   

Air and Liquid Processing

     29,657        26,185   
  

 

 

   

 

 

 

Total Reportable Segments

   $ 73,605      $ 89,068   
  

 

 

   

 

 

 

Income before Income Taxes:

    

Forged and Cast Rolls

   $ 4,140      $ 11,644   

Air and Liquid Processing

     2,474        2,984   
  

 

 

   

 

 

 

Total Reportable Segments

     6,614        14,628   

Other expense, including corporate costs

     (2,774     (3,008
  

 

 

   

 

 

 

Total

   $ 3,840      $ 11,620   
  

 

 

   

 

 

 

 

12


Table of Contents
11. Litigation (claims not in thousands)

The Corporation and its subsidiaries are involved in various claims and lawsuits incidental to their businesses. In addition, it is also subject to asbestos litigation as described below.

Asbestos Litigation

Claims have been asserted alleging personal injury from exposure to asbestos-containing components historically used in some products of predecessors of the Corporation’s Air & Liquid Systems Corporation subsidiary (“Asbestos Liability”) and of an inactive subsidiary in dissolution. Those subsidiaries, and in some cases the Corporation, are defendants (among a number of defendants, often in excess of 50) in cases filed in various state and federal courts.

Asbestos Claims

The following table reflects approximate information about the claims for Asbestos Liability against the subsidiaries and the Corporation, along with certain asbestos claims asserted against the inactive subsidiary in dissolution, for the three months ended March 31, 2012:

 

Open claims at end of period

     8,018 (1) 

Gross settlement and defense costs (in 000’s)

   $     4,853   

Claims resolved

     215   

 

  (1) Included as “open claims” are approximately 1,663 claims classified in various jurisdictions as “inactive” or transferred to a state or federal judicial panel on multi-district litigation, commonly referred to as the MDL.

A substantial majority of the settlement and defense costs reflected in the above table were paid by insurers. Because claims are often filed and can be settled or dismissed in large groups, the amount and timing of settlements, as well as the number of open claims, can fluctuate significantly from period to period. In 2006, for the first time, a claim for Asbestos Liability against one of the Corporation’s subsidiaries was tried to a jury. The trial resulted in a defense verdict. Plaintiffs appealed that verdict and in 2008 the California Court of Appeals reversed the jury verdict and remanded the case back to the trial court.

Asbestos Insurance

Certain of the Corporation’s subsidiaries and the Corporation have an arrangement (the “Coverage Arrangement”) with insurers responsible for historical primary and some first-layer excess insurance coverage for Asbestos Liability (the “Paying Insurers”). Under the Coverage Arrangement, the Paying Insurers accept financial responsibility, subject to the limits of the policies and based on fixed defense percentages and specified indemnity allocation formulas, for pending and future claims for Asbestos Liability. The claims against the Corporation’s inactive subsidiary that is in dissolution proceedings, numbering approximately 300 as of March 31, 2012, are not included within the Coverage Arrangement. The Corporation believes that the claims against the inactive subsidiary in dissolution are immaterial.

The Coverage Arrangement includes an acknowledgement that Howden North America, Inc. (“Howden”) is entitled to coverage under policies covering Asbestos Liability for claims arising out of the historical products manufactured or distributed by Buffalo Forge, a former subsidiary of the Corporation (the “Products”). The Coverage Arrangement does not provide for any prioritization on access to the applicable policies or monetary cap other than the limits of the policies, and, accordingly, Howden may access the policies at any time for any covered claim arising out of a Product. In general, access by Howden to the policies covering the Products will erode the coverage under the policies available to the Corporation and the relevant subsidiaries for Asbestos Liability alleged to arise out of not only the Products but also other historical products of the Corporation and its subsidiaries covered by the applicable policies.

 

13


Table of Contents

On February 24, 2011, the Corporation and its Air & Liquid Systems Corporation subsidiary filed a lawsuit in the United States District Court for the Western District of Pennsylvania against thirteen domestic insurance companies, certain underwriters at Lloyd’s, London and certain London market insurance companies, and Howden. The lawsuit seeks a declaratory judgment regarding the respective rights and obligations of the parties under excess insurance policies not included within the Coverage Arrangement that were issued to the Corporation from 1981 through 1984 as respects claims against the Corporation and its subsidiary for Asbestos Liability and as respects asbestos bodily-injury claims against Howden arising from the Products. Various counterclaims, cross claims and third party claims have been filed in the litigation.

Asbestos Valuations

In 2006, the Corporation retained Hamilton, Rabinovitz & Associates, Inc. (“HR&A”), a nationally recognized expert in the valuation of asbestos liabilities, to assist the Corporation in estimating the potential liability for pending and unasserted future claims for Asbestos Liability. HR&A was not requested to estimate asbestos claims against the inactive subsidiary in dissolution or the former division, which the Corporation believes are immaterial. Based on this analysis, the Corporation recorded a reserve for Asbestos Liability claims pending or projected to be asserted through 2013 as at December 31, 2006. HR&A’s analysis was updated in 2008, and additional reserves were established by the Corporation as at December 31, 2008 for Asbestos Liability claims pending or projected to be asserted through 2018. HR&A’s analysis was most recently updated in 2010, and additional reserves were established by the Corporation as at December 31, 2010 for Asbestos Liability claims pending or projected to be asserted through 2020. The methodology used by HR&A in its projection in 2010 of the operating subsidiaries’ liability for pending and unasserted potential future claims for Asbestos Liability, which is substantially the same as the methodology employed by HR&A in the 2006 and 2008 estimates, relied upon and included the following factors:

 

   

HR&A’s interpretation of a widely accepted forecast of the population likely to have been exposed to asbestos;

 

   

epidemiological studies estimating the number of people likely to develop asbestos-related diseases;

 

   

HR&A’s analysis of the number of people likely to file an asbestos-related injury claim against the subsidiaries and the Corporation based on such epidemiological data and relevant claims history from January 1, 2008 to August 30, 2010;

 

   

an analysis of pending cases, by type of injury claimed and jurisdiction where the claim is filed;

 

   

an analysis of claims resolution history from January 1, 2008 to August 30, 2010 to determine the average settlement value of claims, by type of injury claimed and jurisdiction of filing; and

 

   

an adjustment for inflation in the future average settlement value of claims, at an annual inflation rate based on the Congressional Budget Office’s ten year forecast of inflation.

Using this information, HR&A estimated in 2010 the number of future claims for Asbestos Liability that would be filed through the year 2020, as well as the settlement or indemnity costs that would be incurred to resolve both pending and future unasserted claims through 2020. This methodology has been accepted by numerous courts. For purposes of its consolidated financial statements for the three months ended March 31, 2012, the Corporation reviewed its current Asbestos Liability and ultimately utilized the estimate by HR&A completed in 2010, as updated by the Corporation to reflect its Asbestos Liability expenditures through March 31, 2012.

 

14


Table of Contents

In conjunction with developing the aggregate liability estimate referenced above, the Corporation also developed an estimate of probable insurance recoveries for its Asbestos Liabilities. In developing the estimate, the Corporation considered HR&A’s projection for settlement or indemnity costs for Asbestos Liability and management’s projection of associated defense costs (based on the current defense to indemnity cost ratio), as well as a number of additional factors. These additional factors included the Coverage Arrangement, self-insured retentions, policy exclusions, policy limits, policy provisions regarding coverage for defense costs, attachment points, prior impairment of policies and gaps in the coverage, policy exhaustions, insolvencies among certain of the insurance carriers, the nature of the underlying claims for Asbestos Liability asserted against the subsidiaries and the Corporation as reflected in the Corporation’s asbestos claims database, as well as estimated erosion of insurance limits on account of claims against Howden arising out of the Products. In addition to consulting with the Corporation’s outside legal counsel on these insurance matters, the Corporation retained in 2010 a nationally-recognized insurance consulting firm to assist the Corporation with certain policy allocation matters that also are among the several factors considered by the Corporation when analyzing potential recoveries from relevant historical insurance for Asbestos Liabilities. Based upon all of the factors considered by the Corporation, and taking into account the Corporation’s analysis of publicly available information regarding the credit-worthiness of various insurers, the Corporation estimated the probable insurance recoveries for Asbestos Liability and defense costs through 2020. Although the Corporation believes that the assumptions employed in the insurance valuation were reasonable and previously consulted with its outside legal counsel and insurance consultant regarding those assumptions, there are other assumptions that could have been employed that would have resulted in materially lower insurance recovery projections.

Based on the analyses described above, the Corporation’s reserve at December 31, 2010 for the total costs, including defense costs, for Asbestos Liability claims pending or projected to be asserted through 2020 was $218,303,000,of which approximately 85% was attributable to settlement costs for unasserted claims projected to be filed through 2020 and future defense costs. The reserve at March 31, 2012 was $192,799,000. While it is reasonably possible that the Corporation will incur additional charges for Asbestos Liability and defense costs in excess of the amounts currently reserved, the Corporation believes that there is too much uncertainty to provide for reasonable estimation of the number of future claims, the nature of such claims and the cost to resolve them beyond 2020. Accordingly, no reserve has been recorded for any costs that may be incurred after 2020.

The Corporation’s receivable at December 31, 2010 for insurance recoveries attributable to the claims for which the Corporation’s Asbestos Liability reserve has been established, including the portion of incurred defense costs covered by the Coverage Arrangement, and the probable payments and reimbursements relating to the estimated indemnity and defense costs for pending and unasserted future Asbestos Liability claims, was $141,839,000 ($122,843,000 as of March 31, 2012). The insurance receivable recorded by the Corporation does not assume any recovery from insolvent carriers, and substantially all of the insurance recoveries deemed probable were from insurance companies rated A – (excellent) or better by A.M. Best Corporation. There can be no assurance, however, that there will not be further insolvencies among the relevant insurance carriers, or that the assumed percentage recoveries for certain carriers will prove correct. The difference between insurance recoveries and projected costs is not due to exhaustion of all insurance coverage for Asbestos Liability. The Corporation and the subsidiaries have substantial additional insurance coverage which the Corporation expects to be available for Asbestos Liability claims and defense costs the subsidiaries and it may incur after 2020. However, this insurance coverage also can be expected to have gaps creating significant shortfalls of insurance recoveries as against claims expense, which could be material in future years.

The amounts recorded by the Corporation for Asbestos Liabilities and insurance receivables rely on assumptions that are based on currently known facts and strategy. The Corporation’s actual expenses or insurance recoveries could be significantly higher or lower than those recorded if assumptions used in the Corporation’s or HR&A’s calculations vary significantly from actual results. Key variables in these assumptions are identified above and include the number and type of new claims to be filed each year, the average cost of disposing of each such new claim, average annual defense costs, the resolution of coverage issues with insurance carriers, and the solvency risk with respect to the relevant insurance carriers. Other factors that may affect the Corporation’s Asbestos Liability and ability to recover under its insurance policies include uncertainties surrounding the litigation process from jurisdiction to jurisdiction and from case to case, reforms that may be made by state and federal courts, and the passage of state or federal tort reform legislation.

 

15


Table of Contents

The Corporation intends to evaluate its estimated Asbestos Liability and related insurance receivables as well as the underlying assumptions on a regular basis to determine whether any adjustments to the estimates are required. Due to the uncertainties surrounding asbestos litigation and insurance, these regular reviews may result in the Corporation incurring future charges; however, the Corporation is currently unable to estimate such future charges. Adjustments, if any, to the Corporation’s estimate of its recorded Asbestos Liability and/or insurance receivables could be material to operating results for the periods in which the adjustments to the liability or receivable are recorded, and to the Corporation’s liquidity and consolidated financial position.

 

12. Environmental Matters

The Corporation is currently performing certain remedial actions in connection with the sale of real estate previously owned. Settlements were paid by the Corporation’s insurance carriers at two third-party landfill sites where it was named a Potentially Responsible Party. In addition, as a result of a sale of a segment in 2003, the Corporation retained the liability to remediate certain environmental contamination and has agreed to indemnify the buyer against third-party claims arising from the discharge of certain contamination, the costs for which were accrued at the time of sale.

Environmental exposures are difficult to assess and estimate for numerous reasons including lack of reliable data, the multiplicity of possible solutions, the years of remedial and monitoring activity required, and identification of new sites. In the opinion of management and in consideration of advice from the Corporation’s consultants, the potential liability for all environmental proceedings of approximately $1,278,000 at March 31, 2012 is considered adequate based on information known to date.

 

16


Table of Contents

ITEM 2 – MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Executive Overview

The Corporation operates in two business segments – Forged and Cast Rolls and Air and Liquid Processing. The Forged and Cast Rolls segment produces and sells forged-hardened steel rolls and cast iron and steel rolls to manufacturers of steel and aluminum throughout the world. For the Forged and Cast Rolls segment, business activity in North America has improved slightly from the end of 2011; however, demand remains weak in Europe and throughout the Pacific Rim, particularly in China where roll inventories are at high levels and several new mill projects have been deferred. Pricing continues to be competitive. For the Air and Liquid Processing segment, increased activity in the fossil-fueled utility market has been encouraging while new construction spending by the institutional markets has yet to exhibit any significant signs of improvement.

Consolidated Results of Operations for the Three Months Ended March 31, 2012 and 2011

Net Sales. Net sales for the three months ended March 31, 2012 and 2011 were $73,605,000 and $89,068,000, respectively. Backlog approximated $261,043,000 at March 31, 2012 versus $260,001,000 as of December 31, 2011 and $357,283,000 as of March 31, 2011. A discussion of sales and backlog for the Corporation’s two segments is included below.

Costs of Products Sold. Costs of products sold, excluding depreciation, as a percentage of net sales approximated 76.4% and 71.2% for the three months ended March 31, 2012 and 2011, respectively. The increase is primarily attributable to the lower volume of shipments, changes in product mix and reduced margins for the Forged and Cast Rolls segment.

Income from Operations. Income from operations for the three months ended March 31, 2012 and 2011 approximated $4,117,000 and $12,129,000, respectively. A discussion of operating results for the Corporation’s two segments is included below.

Forged and Cast Rolls. Sales and operating income for the three months ended March 31, 2012 decreased from the comparable prior year period due to a lower volume of shipments and changes in product mix. Additionally, lack of demand continued to put pressure on pricing and erode margins. Backlog approximated $215,608,000 at March 31, 2012 against $214,449,000 as of December 31, 2011 and $308,210,000 as of March 31, 2011. The decline from a year ago is due to shipments outpacing new orders and declining profitability in backlog. Approximately $79,948,000 of the current backlog is expected to ship after 2012.

Air and Liquid Processing. For the three months ended March 31, 2012, sales for the segment improved when compared to the same period of the prior year. While a higher volume of shipments to the fossil-fueled utility market benefited Aerofin and Buffalo Pumps, results for Buffalo Air Handling improved due to shipment of the balance of the large order for a customer in medical research. Operating income improved from a year ago for each of the divisions except Buffalo Pumps which was adversely impacted by product mix. Backlog at March 31, 2012 and December 31, 2011 were comparable at approximately $45,500,000 but below March 31, 2011 of $49,073,000 which included the large order for the customer in medical research mentioned above. The majority of the backlog will ship in 2012.

Other Income (Expense). The fluctuation is primarily attributable to fluctuations in foreign exchange gains and losses.

Income Taxes. The increase in the effective income tax rate is attributable to a higher proportion of income before income taxes expected to be generated by the U.S. operations which are taxed at a statutory rate of 35% versus approximately 25% in the U.K.

Net Income and Earnings per Common Share. As a result of the above, the Corporation’s net income for the three months ended March 31, 2012 and 2011 equaled $2,000,000 or $0.19 per common share and $7,677,000 or $0.74 per common share, respectively.

 

17


Table of Contents

Liquidity and Capital Resources

Net cash flows provided by operating activities improved for the three months ended March 31, 2012 when compared to the three months ended March 31, 2011. The increase is primarily due to the reduction in accounts receivable resulting from lower sales in the first quarter of 2012 versus 2011.

Net cash flows used in investing activities for the three months ended March 31, 2012 were higher than March 31, 2011 due to a slightly increased level of capital expenditures. Additionally, proceeds were received from a government grant in the prior year by the U.K. operations. As of quarter end, the balance of grant proceeds expected to be received equaled $615,000 (£405,000). As of March 31, 2012, future capital expenditures approximating $7,489,000, to be spent over the next 12-18 months, have been approved.

Net cash flows used in financing activities were comparable for each of the quarters and represented primarily payment of dividends.

As a result of the above, cash and cash equivalents increased $7,834,897 in 2012 and ended the period at $77,722,736 (of which approximately $10,096,000 is held by foreign operations) in comparison to $69,887,839 at December 31, 2011. Repatriation of foreign funds may result in the Corporation accruing and paying additional income tax; however, the majority of such amounts are currently deemed to be permanently reinvested and no additional provision for income tax has been made.

Funds on hand and funds generated from future operations are expected to be sufficient to finance the operational and capital expenditure requirements of the Corporation. The Corporation also maintains short-term lines of credit and an overdraft facility in excess of the cash needs of its businesses. The total available at March 31, 2012 was approximately $9,300,000 (including £3,000,000 in the U.K. and €400,000 in Belgium).

Litigation and Environmental Matters

See Notes 11 and 12 to the condensed consolidated financial statements.

Critical Accounting Pronouncements

The Corporation’s critical accounting policies, as summarized in its Annual Report on Form 10-K for the year ended December 31, 2011, remain unchanged.

Recently Issued Accounting Pronouncements

See Note 1 to the condensed consolidated financial statements.

Forward-Looking Statements

Management’s Discussion and Analysis of Financial Condition and Results of Operations and other sections of the Form 10-Q contain forward-looking statements that reflect the Corporation’s current views with respect to future events and financial performance.

Forward-looking statements are identified by the use of the words “believes,” “expects,” “anticipates,” “estimates,” “projects,” “forecasts” and other expressions that indicate future events and trends. Forward-looking statements speak only as of the date on which such statements are made, are not guarantees of future performance or expectations and involve risks and uncertainties. For the Corporation, these risks and uncertainties include, but are not limited to, those described under Item 1A, Risk Factors, of Part II of this Form 10-Q. In addition, there may be events in the future that the Corporation is not able to predict accurately or control which may cause actual results to differ materially from expectations expressed or implied by forward-looking statements. Except as required by applicable law, the Corporation undertakes no obligation to update any forward-looking statement whether as a result of new information, events or otherwise.

 

18


Table of Contents

ITEM 3 – QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

There were no material changes in the Corporation’s exposure to market risk from December 31, 2011.

ITEM 4 – CONTROLS AND PROCEDURES

(a) Disclosure controls and procedures. An evaluation of the effectiveness of the Corporation’s disclosure controls and procedures as of the end of the period covered by this report was carried out under the supervision, and with the participation, of management, including the principal executive officer and principal financial officer. Disclosure controls and procedures are defined under Securities and Exchange Commission (“SEC”) rules as controls and other procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported within the required time periods. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, the Corporation’s management, including the principal executive officer and principal financial officer, has concluded that the Corporation’s disclosure controls and procedures were effective as of March 31, 2012.

(c) Changes in internal control over financial reporting. There were no changes in the Corporation’s internal control over financial reporting during the quarter ended March 31, 2012, that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

 

19


Table of Contents

PART II – OTHER INFORMATION

AMPCO-PITTSBURGH CORPORATION

 

Item 1 Legal Proceedings

The information contained in Note 11 to the condensed consolidated financial statements (Litigation) is incorporated herein by reference.

 

Item 1A Risk Factors

There are no material changes to the Risk Factors contained in Item 1A to Part I of the Corporation’s Annual Report on Form 10-K for the year ended December 31, 2011.

 

Items 2-5 None

 

Item 6 Exhibits

 

       (3)   Articles of Incorporation and By-laws
     (a)    Articles of Incorporation
        Incorporated by reference to the Quarterly Reports on Form 10-Q for the quarters ended March 31, 1983, March 31, 1984, March 31, 1985, March 31, 1987 and September 30, 1998.
     (b)    By-laws   
        Incorporated by reference to the Quarterly Reports on Form 10-Q for the quarters ended September 30, 1994, March 31, 1996, June 30, 2001 and June 30, 2004.
     (31.1)   Certification of the principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     (31.2)   Certification of the principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     (32.1)   Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     (32.2)   Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   (101)   Interactive Data File (XBRL)

 

20


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  AMPCO-PITTSBURGH CORPORATION
DATE: May 10, 2012   BY:  

/s/ Robert A. Paul

  Robert A. Paul
  Chairman and Chief Executive Officer
DATE: May 10, 2012   BY:  

/s/ Marliss D. Johnson

  Marliss D. Johnson
  Vice President, Controller and Treasurer

 

21


Table of Contents

AMPCO-PITTSBURGH CORPORATION

EXHIBIT INDEX

 

Exhibit      (31.1)    Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     (31.2)    Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     (32.1)    Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     (32.2)    Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
   (101)    Interactive Data File (XBRL)

 

22